AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2012
Jun 25, 2012
30591_dirs_2012-06-25_dc948cff-cd6b-40f3-90bc-ce354847cba5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2012-06-25
Reporting Person: BERTHELSEN SPENCER R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-25 | Common Stock | M | 300 | $8.15 | Acquired | 29600 | Direct |
| 2012-06-25 | Common Stock | S | 300 | $11.48 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 200 | $8.15 | Acquired | 29500 | Direct |
| 2012-06-25 | Common Stock | S | 200 | $11.49 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 300 | $8.15 | Acquired | 29600 | Direct |
| 2012-06-25 | Common Stock | S | 300 | $11.493 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 200 | $8.15 | Acquired | 29500 | Direct |
| 2012-06-25 | Common Stock | S | 200 | $11.50 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 500 | $8.15 | Acquired | 29800 | Direct |
| 2012-06-25 | Common Stock | S | 500 | $11.51 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 228 | $8.15 | Acquired | 29528 | Direct |
| 2012-06-25 | Common Stock | S | 228 | $11.53 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 205 | $8.15 | Acquired | 29505 | Direct |
| 2012-06-25 | Common Stock | S | 205 | $11.54 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 495 | $8.15 | Acquired | 29795 | Direct |
| 2012-06-25 | Common Stock | S | 495 | $11.55 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 700 | $8.15 | Acquired | 30000 | Direct |
| 2012-06-25 | Common Stock | S | 700 | $11.56 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 3500 | $8.15 | Acquired | 32800 | Direct |
| 2012-06-25 | Common Stock | S | 3500 | $11.58 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 1500 | $8.15 | Acquired | 30800 | Direct |
| 2012-06-25 | Common Stock | S | 1500 | $11.582 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 100 | $8.15 | Acquired | 29400 | Direct |
| 2012-06-25 | Common Stock | S | 100 | $11.59 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 1600 | $8.15 | Acquired | 30900 | Direct |
| 2012-06-25 | Common Stock | S | 1600 | $11.60 | Disposed | 29300 | Direct |
| 2012-06-25 | Common Stock | M | 172 | $8.15 | Acquired | 29472 | Direct |
| 2012-06-25 | Common Stock | S | 172 | $11.62 | Disposed | 29300 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-25 | Director Stock Option (right to buy) | $8.15 | M | 10000 | Disposed | 2012-06-30 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 70 | Indirect |
Footnotes
F1: Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/12. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 3/1/12.
More from IONIS PHARMACEUTICALS INC
Board/Management Information
2026
Jun 8
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27